Thursday, March 3, 2022
1:00PM – 2:00PM ET
Please note this TeleECHO program is 1:00PM Eastern, 12:00PM Central, 11:00AM Mountain and 10:00AM Pacific.
The acute myeloid leukemia (AML) TeleECHO series will explore strategies to promptly recognize, diagnose, and manage AML. This TeleECHO series provides an interactive platform that includes didactic programming in addition to case-based discussion on selecting therapeutic options and managing patients with AML.
Amir T. Fathi, MD
Associate Professor of Medicine, Harvard Medical School
Program Director, Center for Leukemia
After completing the CME activity, learners should be better able to:
- Evaluate features of novel chemotherapy formulations to enhance safety and efficacy of treatment and the rationale for expanding use of induction chemotherapy in AML
- Formulate best practices based on the latest evidence for selection of induction therapy in older adults with AML
- Discuss best practices in use of induction chemotherapy in the context of stem cell transplant in the modern AML treatment paradigm
This activity is intended for community-based hematologists, medical oncologists, pathologists, oncology nurses, nurse practitioners, and pharmacists to ensure an up-to-date understanding of the latest data on managing acute myeloid leukemia.
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the treatment of patients with AML Credits: 1.0 ANCC Contact Hour.
CNE Accreditation Statement: Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.
Med Learning Group makes every effort to develop CME activities that are science-based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at firstname.lastname@example.org
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at email@example.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/